IP Library Granted Patent US 12,419,830
Granted Patent B2
US 12,419,830 · App. 18/220,371 · Granted Sep 23, 2025

Compositions and methods for treating intervertebral discs

Inventor: Matthew F. Myntti (St. Augustine, FL)
Assignee: Next Science IP Holdings Pty Ltd
A61K9/0024A61K31/194A61P31/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,419,830
App. No.
18/220,371
Granted
Sep 23, 2025
Kind
B2
Abstract

A biocompatible antimicrobial composition effective against microbial biofilms, including in vivo biofilms containing gram-positive bacteria, can be delivered to and used near the spinal column of vertebrates. Once introduced to an area colonized with a bacterial biofilm, particularly an intervertebral disc, the antimicrobial composition weakens the EPS/ECPS macromolecules of the biofilm, which makes the entire biofilm structure susceptible to being dislodged from the affected area or biosorbed. Additionally or alternatively, certain of the subcomponents of the solute component, as well as perhaps the organic liquid(s) of the solvent component, might lyse microbes, particularly gram-positive bacteria, previously protected by the EPS/ECPS macromolecules. Swelling of and around previously impacted intervertebral discs can be reduced or eliminated, often resulting in appreciable reductions in patient pain levels.

Claims (17)

1. A method for treating a spinal column area colonized with a biofilm that comprises at least one type of gram-positive bacterium which includes Propionibacterium acnes , said area being an intervertebral disc or tissue adjacent thereto, said method comprising introducing to said area, via injection, a liquid composition effective to weaken the macromolecules of said biofilm and, optionally, lyse the cell walls of one or more types of bacteria contained therein, said liquid composition having an effective solute concentration of 0.1 to 1.1 Osm/L, wherein said liquid composition comprises a solvent component and a solute component, wherein said solute component comprises a buffer precursor that comprises at least one weak acid and at least one salt of said at least one weak acid.

2. The method of claim 1 wherein said liquid has a dynamic viscosity of no more than about 125 mPa·s.

3. The method of claim 2 wherein said liquid increases in viscosity after said introduction.

4. The method of claim 3 wherein said liquid solidifies after said introduction.

5. The method of claim 1 wherein said liquid increases in viscosity after said introduction.

6. The method of claim 5 wherein said liquid solidifies after said introduction.

7. The method of claim 5 wherein said liquid composition has an effective solute concentration of no more than 600 mOsm/L.

8. The method of claim 1 wherein the lower limit of said effective solute concentration is 200 mOsm/L.

9. The method of claim 1 wherein the upper limit of said effective solute concentration is 600 mOsm/L.

10. The method of claim 1 wherein said liquid composition has a pH of from 5.0 to 6.5.

11. The method of claim 10 wherein said liquid composition consists of the solvent component and the solute component.

12. The method of claim 1 wherein said buffer precursor comprises citric acid and a salt of citric acid.

13. The method of claim 12 wherein said solute component further comprises at least one of salicylic acid and less than 1% (w/v) surfactant.

14. The method of claim 1 wherein said solvent component consists of water and at least one organic liquid.

15. The method of claim 14 wherein said solvent component exhibits a δ p value of less than 15.2 MPa 1/2 .

16. The method of claim 1 wherein said solute component further comprises less than 1% (w/v) surfactant.

17. A method for treating a spinal column area colonized with a biofilm that comprises Propionibacterium acnes , said method comprising introducing to an intervertebral disc or tissue adjacent thereto, via injection, a liquid composition effective to weaken the macromolecules of said biofilm and, optionally, lyse the cell walls of said at least one type of gram-positive bacterium contained therein, said liquid composition having an effective solute concentration of 0.1 to 1.1 Osm/L and a pH of from 5.0 to 6.5, said liquid composition comprising a solvent component and a solute component, wherein said solute component comprises a buffer precursor that comprises at least one weak acid and at least one salt of said at least one weak acid and wherein said solvent component exhibits a δ p value of less than 15.2 MPa 1/2 and consists of water and at least one organic liquid.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2025
From: NEXT SCIENCE IP HOLDINGS PTY LTD
To: OSARTIS GMBH
Reel/Frame 072590/0763 →
Continuity (4)
Continuation 16765421
Provisional Application 62748431 · Oct 20, 2018
Provisional Application 62588401 · Nov 19, 2017
Related Publication 20230355510A1 · Nov 9, 2023
References Cited (42)
US 5661170A · Chodosh · 1997 [cited by applicant]
US 7959943B2 · Hissong et al. · 2011 [cited by applicant]
US 7976873B2 · Myntti et al. · 2011 [cited by applicant]
US 7976875B2 · Myntti · 2011 [cited by applicant]
US 7993675B2 · Oliver et al. · 2011 [cited by applicant]
US 8389022B2 · Bignozzi et al. · 2013 [cited by applicant]
US 8784790B2 · Myntti et al. · 2014 [cited by applicant]
US 8940792B2 · Myntti · 2015 [cited by applicant]
US 9314017B2 · Myntti · 2016 [cited by applicant]
US 9427417B2 · Myntti · 2016 [cited by applicant]
US 10021876B2 · Myntti · 2018 [cited by applicant]
US 10166208B2 · Myntti · 2019 [cited by applicant]
US 10477860B2 · Myntti · 2019 [cited by applicant]
US 10780037B2 · Myntti · 2020 [cited by applicant]
US 11090369B2 · Myntti · 2021 [cited by applicant]
US 20130244972A1 · Ben-Shalom · 2013 [cited by applicant]
US 20160073628A1 · Myntti · 2016 [cited by applicant]
US 20170042848A1 · Ala'Aldeen · 2017 [cited by applicant]
US 20170340590A1 · Myntti · 2017 [cited by applicant]
US 20180369176A1 · Myntti et al. · 2018 [cited by applicant]
US 20190262433A1 · Myntti · 2019 [cited by applicant]
US 20200085037A1 · Myntti · 2020 [cited by applicant]
US 20200085038A1 · Myntti · 2020 [cited by applicant]
US 20210037815A1 · Myntti · 2021 [cited by applicant]
BioNumbers, “Osmolarity of sea water”, https://bionumbers.hms.harvard.edu/bionumber.aspx?&id=100802&ver=5, accessed Dec. 3, 2021 (Year: 2021). [cited by applicant]
Bo Li, MD et al. “Association Between Lumbar Disc Degeneration and Propionibacterium acnes Infection”, SPINE, vol. 41, No. 13, 2016, pp E764-E769. [cited by applicant]
Bustle, “How Swimming in The Ocean Can Mess With Your Skin”, https://www.bustle.com/articles/166526-will-ocean-water-heal-a-pimple-the-truth-behind-this-alleged-treatment, accessed Dec. 3, 2021 (Year: 2016). [cited by applicant]
EPO Art. 94(3) Communication in EP appl. No. 18879170.1, mailed Oct. 17, 2022 (6 pp.). [cited by applicant]
Extended search report in EP 188791170.1, mailed Nov. 23, 2020. [cited by applicant]
Flottweg, “Dynamic viscosity”, https://www.flottweg.com/wiki/separation-technology/dynamic-viscosity/, accessed Dec. 3, 2021 (Year: 2021). [cited by applicant]
Manu N. Capoor et al, “Prevalence of Propionibacterium acnes in Intervertebral Discs of Patients Undergoing Lumbar Microdiscectomy: A Prospective Cross-Sectional Study”, PLOS One, Aug. 18, 2016, 8 pages. [cited by applicant]
Manu N. Capoor et al, “Priopionibacterium acnes biofilm is present in intervertebral discs of patients undergoing microdiscectomy”, PLOS One, Apr. 3, 2017, 11 pages. [cited by applicant]
McLaughlin et al., “Propionibacterium acnes and Acne Vulgaris: New Insights from the Integration of Population Genetic, Multi-Omic, Biochemical and Host-Microbe Studies”, Microorganisms, 2019, 7, pp. 128. (Year: 2019). [cited by applicant]
Michael F. Coscia, MD et al, “Propionibacterium acnes, Coagulase-Negative Staphylococcus, and the “Biofilm-like” Intervertebral Disc”, SPINE, vol. 41, No. 24, 2016, pp. 1860-1865. [cited by applicant]
Omni Calculator, “Water Viscosity Calculator”. https://www.omnicalculator.com/physics/water-viscosity#what-is-the-viscosity-of-water, accessed Dec. 3, 2021 (Year: 2021). [cited by applicant]
Ulivieri et al., “Prevention of post-operative infections in spine surgery by wound irrigation with a solution of povidone-iodine and hydrogen peroxide”, Arch Orthop Trauma Surg, (2011 ), 131, pp. 1203-1206. (Year: 2011… [cited by applicant]
Zhi Shan, MD et al, “The Influence of Direct Inoculation of Propionibacterium acnes on Modic Changes in the Spine”, The Journal of Bone and Joint Surgery, 2017, pp. 472-481 (plus cover page). [cited by applicant]
Zhi Shan, MD et al. “Propionibacterium acnes Incubation in the Discs Can Result in Time-Dependent Modic Changes”, SPINE, vol. 42, No. 21, 2017. pp. 1595-1603. [cited by applicant]
Office Action issued May 23, 2024 in corresponding Australian Patent Application No. 2018367660, 4 pages. [cited by applicant]
Office Action issued Nov. 9, 2023 in corresponding Australian Patent Application No. 2018367660, 4 pages. [cited by applicant]
Office Action issued Nov. 15, 2024 in CA Patent Application No. 3,094,529, 6 pages. [cited by applicant]
EPO Art. 94(3) Communication in EP appl. No. 188791170.1, mailed Sep. 20, 2024 (5 pp.). [cited by applicant]